Evidence map›Paper›PMID 35705278›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Pulmonary Veno-occlusive Disease that Developed Following Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Kenichiro Takeda, Akira Naito, Toshihiko Sugiura, Masaki Ishige, Kohei Shikano, Mitsuhiro Abe, Hajime Kasai, Shota Miyakuni, Shu Yamashita, Ayako Shigeta and 2 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kenichiro TakedaDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Akira NaitoDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Toshihiko SugiuraDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Masaki IshigeDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Kohei ShikanoDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Mitsuhiro AbeDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Hajime KasaiDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Shota MiyakuniDepartment of Cardiology, Kameda Medical Center, Japan.
Shu YamashitaDepartment of Cardiology, Kameda Medical Center, Japan.
Ayako ShigetaDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Seiichiro SakaoDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Takuji SuzukiDepartment of Respirology, Graduate School of Medicine, Chiba University, Japan.
Chiba University · JPKameda Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of pulmonary veno-occlusive disease (PVOD) induced by allo-hematopoietic stem cell transplantation (HSCT) in a 48-year-old man who was diagnosed with acute myeloid leukemia. Five months after transplantation, he developed dyspnea and was diagnosed with pulmonary hypertension based on right heart catheterization. Although he received treatment with pulmonary vasodilators, diuretics, and corticosteroids, his pulmonary artery pressure did not decrease, and his pulmonary edema worsened. Based on the clinical course, hypoxemia, diffusion impairment, and computed tomography findings, the patient was diagnosed with HSCT-related PVOD. Critical attention should be paid to dyspnea after HSCT for the early diagnosis of PVOD.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcutePulmonary Veno-Occlusive DiseaseDyspneaHumansLungMaleMiddle Agedacute myeloid leukemia (AML)hematopoietic stem cell transplantation (HSCT)pulmonary veno-occlusive disease (PVOD)

Identifiers

PMID35705278
PMCPMC9908400
OpenAlexW4283014602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.